WellPoint among 13 picked to join California exchange
California residents who choose to buy health insurance through the state exchange being created by the Affordable Care Act may end up paying higher premiums.
Bloomberg News
Articles
Stonegate raises $115M to fund jumbo mortgage expansion
The fast-growing Indianapolis-based firm will use the funds to fuel originations of loans not intended for government-backed programs, as well as to build its portfolio of servicing contracts, CEO Jim Cutillo said.
Sanctions against Penn State were necessary, NCAA tells judge
The National Collegiate Athletic Association’s sanctions against Pennsylvania State University for its role in the Jerry Sandusky sex-abuse scandal were needed to protect the integrity of intercollegiate sports, a lawyer for the Indianapolis-based association argued in court Monday.
Canada’s Supreme Court won’t hear Lilly appeal on Zyprexa
Eli Lilly claims recent decisions by Canadian courts invalidating 17 drug patents have made the country an outlier among major developed countries.
National fraternities face more legal risk after court ruling
An Indiana appeals court ruling regarding the death of a Wabash College freshman may force national fraternities to take more responsibility for misconduct at chapter houses.
Lechleiter’s surgery to repair heart goes as planned
Eli Lilly and Co. CEO John Lechleiter underwent a scheduled surgery Monday for a heart defect, and the repair to the aorta is functioning as intended, the Indianapolis-based drugmaker said.
Three WellPoint directors step down, cite personal reasons
Lenox Baker, Sheila Burke and Susan Bayh resigned from the board effective immediately, Indianapolis-based WellPoint said Monday in a regulatory filing.
Lilly stops development on cancer drug after failed study
The drug, enzastaurin, was in the most advanced stage of testing and had been expected to generate $260 million in annual sales by 2018.
Duke Realty puts 17 Midwest office buildings on block
The developer is selling the buildings in Cincinnati, Cleveland and St. Louis to increase its emphasis on industrial properties. A research firm values them at $149 a square foot, or a total of about $350 million.
IU’s Kelley School of Business getting new dean
Idalene Kesner will be the first woman to lead the school, and one of only a small handful of female business school deans in the United States.
More demand for mall space boosts Simon earnings
The Indianapolis-based owner of retail centers raised its expectations for the fiscal year after reporting solid gains in occupancy, rent revenue and earnings for the first quarter.
Lilly suing J&J for patent rights in Alzheimer’s drug race
Eli Lilly and Co. is seeking to revoke a patent held by a Johnson & Johnson unit, arguing at a London court it might delay availability of a potential treatment for Alzheimer’s disease.
Dow AgroSciences grows sales, earnings to new heights
Record sales for seeds and new crop protection products helped boost revenue 14 percent at Indianapolis-based Dow AgroSciences LLC in its new fiscal year.
Lafayette key to Subaru ending dealer shortages, exec says
Fuji Heavy Industries Ltd., the Japanese maker of Subaru cars, intends to end a shortage of its vehicles at U.S. dealerships soon by expanding capacity at its Lafayette plant.
Employer health coverage on 10-year fall, study says
Indiana, Michigan and South Carolina saw the steepest declines in employer-backed coverage from 2000 to 2011, according to a study released Thursday.
Simon taps Pace bonds to fund energy projects
Indianapolis-based Simon Property Group Inc. is among borrowers funding projects from rooftop solar panels to energy-savings systems using so-called Pace financing.
Kelley School launching MBA for midcareer physicians
The idea behind the program, which starts in September, is that doctors can no longer leave the business aspect of their jobs to the finance guys while maintaining their integrity as healers.
WellPoint jumps after feds reverse Medicare decision
Shares of Indianapolis-based WellPoint rose along with those of other medical insurers Tuesday morning after the U.S. government reversed a decision to cut a key Medicare payment rate, offering them an increase instead.
New $100M plan to map human brain could boost Lilly
President Obama on Tuesday announced a campaign designed to develop treatments for some of the least understood brain disorders, an effort that could benefit health care giants Eli Lilly and Co. and others.
J&J wins OK for first in new class of diabetes drugs
Johnson & Johnson, the world’s largest seller of health-care products, won approval for the first in a new family of diabetes drugs, giving them the edge against rivals including Eli Lilly and Co. that are developing similar medicines.